tiprankstipranks
Trending News
More News >
Brainstorm Cell Therapeutics (BCLI)
OTHER OTC:BCLI
US Market

Brainstorm Cell Therapeutics (BCLI) Ownership - Who Owns Brainstorm Cell Therapeutics?

Compare
571 Followers

Brainstorm Cell Therapeutics (BCLI) Ownership Overview

7.19%0.03%1.32%91.46%
1.32% Other Institutional Investors
91.46% Public Companies and
Individual Investors
The ownership structure of Brainstorm Cell Therapeutics (BCLI) stock is a mix of institutional, retail, and individual investors. , 7.19% is owned by Insiders, and 91.46% is owned by Public Companies and Individual Investors.
The ownership structure of Brainstorm Cell Therapeutics (BCLI) stock is a mix of institutional, retail, and individual investors. Approximately 1.35% of the company’s stock is owned by Institutional Investors, 7.19% is owned by Insiders, and 91.46% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
334,349Insider3.03%184,895
79,515Insider0.72%43,972
68,464Insider0.62%37,861
52,000Insider0.47%28,756
48,229Insider0.44%26,671
44,349Insider0.40%24,525
43,777Insider0.40%24,209
41,054Insider0.37%22,703
31,465Insider0.29%17,400
26,734Institution0.27%16,709

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,152Institution0.03%1,743

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Brainstorm Cell Therapeutics (BCLI)?
According to the latest TipRanks data, approximately 1.32% of the company's stock is held by institutional investors, 7.19% is held by insiders, and 91.46% is held by retail investors.
    What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.32% of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors.
      What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 91.46% of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors.
        Who owns the most shares of Brainstorm Cell Therapeutics (BCLI)?
        Chaim Lebovits owns the most shares of Brainstorm Cell Therapeutics (BCLI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.